ArticleMolecular plant pathology2026
ACR3 as a Key Regulator Antimicrobial Lipopeptide Synthesis and Efflux in Bacillus velezensis HN-1.
Article in Molecular plant pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Bacillus velezensis is known for producing and secreting antimicrobial lipopeptides, yet the regulatory mechanisms behind these processes remain unclear. In this study, we constructed arsenite transporter protein gene (acr3)-deficient strains (HN-1ΔQ acr3) and complementary strains (HN-1ΔC acr3) to elucidate the roles of ACR3 in antimicrobial lipopeptide synthesis and efflux. Our findings demonstrate that ACR3 dysfunction compromised swarming and biofilm formation, completely abolishing the antifungal capabilities of the HN-1ΔQ acr3 strains. Transcriptomic analysis and reverse transcription-quantitative PCR revealed significant downregulation of lipopeptide biosynthesis genes, including sfp, fenD and bmyC, in HN-1ΔQ acr3. Notably, the addition of purified ACR3 protein restored the expression of lipopeptide biosynthesis genes and partially rescued antifungal activities in the HN-1ΔQ acr3 strains. Furthermore, yeast two-hybrid assays indicated an interaction between ACR3 and proteins involved in cell survival, substrate uptake and antifungal activities, such as ribose ABC transporter substrate-binding protein (RbsB), fengycin synthetases and phosphopantetheine transferases. In parallel, our findings indicate that ACR3 interacts with the ABC transporter pathway to tune antifungal lipopeptide transport in Bacillus velezensis. Collectively, these results suggest that ACR3 functions as a crucial regulator, mediating both the synthesis and efflux of lipopeptides in B. velezensis. These research establish an experimental foundation for elucidating the mechanisms of antimicrobial compound synthesis and secretion in B. velezensis and provide a theoretical basis for the optimisation and engineering of high-yield biocontrol strains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.